Skip to main content

Table 3 Changes in surrogate markers of liver fibrosis in HIV/HCV infection in the longitudinal analysis.

From: Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rsI2979860 polymorphism of the IL28B gene

HCV genotype 1 non 1 all
IL28B genotype CC
n = 13 (33%)
CT
n = 23 (59%)
TT
n = 3 (8%)
all
(n = 39)
all
(n = 15)
all
(n = 56)
Change of Stiffness/month [k Pa/mo nth] -0.08 ± 0.2 0.003 ± 0.4 0.2 ± 0.4 -0.01 ± 0.4 0.04 ± 0.4 0.003 ± 0.4
Change of APRI/month 0.001 ± 0.06 0.007 ± 0.05 0.006 ± 0.01 -0.004 ± 0.05 -0.06 ± 0.3 -0.02 ± 0.1
Change of FIB-4/month -0.01 ± 0.05 0.01 ± 0.07 0.02 ± 0.03 0.008 ± 0.06 -0.04 ± 0.3 -0.006 ± 0.2
Period [months] 19 (5 - 48) 27 (12 - 50) 49 (14 - 50) 22 (5 - 50) 24 (9 - 47) 25 (5 - 50)